VFEND is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Roerig. The primary component is Voriconazole.
Product ID | 0049-4190_4be3e0d5-6bae-4ebb-8691-cec3d1781ec9 |
NDC | 0049-4190 |
Product Type | Human Prescription Drug |
Proprietary Name | VFEND |
Generic Name | Voriconazole |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2012-10-24 |
Marketing Category | NDA / NDA |
Application Number | NDA021267 |
Labeler Name | Roerig |
Substance Name | VORICONAZOLE |
Active Ingredient Strength | 10 mg/mL |
Pharm Classes | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2012-10-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021267 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-10-24 |
Ingredient | Strength |
---|---|
VORICONAZOLE | 10 mg/mL |
SPL SET ID: | 08d08721-1f4c-478a-8abf-d9c402d50553 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0049-3160 | VFEND | voriconazole |
0049-3170 | VFEND | voriconazole |
0049-3180 | VFEND | voriconazole |
0049-3190 | VFEND | voriconazole |
55154-2725 | VFEND | VFEND |
0049-4190 | VFEND | VFEND |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VFEND 78469910 3017665 Live/Registered |
PFIZER IRELAND PHARMACEUTICALS 2004-08-19 |
VFEND 76269065 not registered Dead/Abandoned |
Pfizer Inc. 2001-06-07 |
VFEND 75122046 2455588 Live/Registered |
PFIZER IRELAND PHARMACEUTICALS 1996-06-19 |